Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.45
Bid: 3.40
Ask: 3.50
Change: -0.175 (-4.83%)
Spread: 0.10 (2.941%)
Open: 3.625
High: 3.625
Low: 3.45
Prev. Close: 3.625
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Arecor Therapeutics wins patent approval in US

Wed, 23rd Mar 2022 20:53

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Hydrogen Utopia International PLC - London-based company specialising in turning non-recyclable mixed waste plastic into carbon-free fuels - Says it believes that building new waste plastic to energy plants could be "significant" in allowing local communities across Europe to lessen the impacts of the gas and energy supply crisis and the anticipated market changes brought about by ongoing sanctions against Russia and the reluctance to rely upon it as an energy supplier in the future.

----------

ValiRx PLC - Nuneaton, England-based drug development company - Reports it is progressing towards the completion of its proposed sub-licence of VAL201 to TheoremRx Inc. VAL201's primary indication is for prostate cancer, with potential further research & development in breast and ovarian cancer. Company says TheoremRx continues to make good progress with its financing but notes that current global macro-economic events have impacted the timelines. First payments to ValiRx are expected on or before the end of June.

----------

Arecor Therapeutics PLC - Essex, England-based biopharmaceutical company - Wins patent grant from US Patent & Trademark Office protecting novel formulations of the group's insulin products, AT247 and AT278. Chief Scientific Officer Jan Jezek says: "This recently granted US patent, the first within the group's comprehensive insulin IP strategy, is a significant milestone, and we will continue to strengthen our IP portfolio with additional patent applications already in progress."

----------

GENinCode PLC - Manchester-based genetic testing company - Collaborates with Indiana University School of Medicine on a study using its Cardio inCode-SCORE for the risk assessment of patients for onset of atherosclerotic cardiovascular disease.

----------

88 Energy Ltd - oil exploration company focused on Alaska - Reaches total depth of 7,334 feet at Merlin-2 well and ceases drilling. Company says all three target reservoirs at the well were penetrated with elevated gas readings. Adds observations of cutting samples have revealed oil shows over all targets. Wireline logging is due to commence shortly.

----------

i(x) Net Zero PLC - Jersey-based investment company focused on sustainability - Says portfolio company Context Labs has secures a multi-year partnership with energy company Williams Co Inc. Partnership for the deployment of its Immutably-based Decarbonization as a Service platform. The deployment of the enterprise data fabric solution will facilitate Williams' energy transition, i(x) explains.

----------

All Star Minerals PLC - Haywards Heath, England-based mining services investor - Appoints Jason Brewer as chief executive officer. Current CEO Ian Harebottle reverts to the position of non-executive director with immediate effect. Says restructuring has been driven by "recent developments in Europe".

----------

Panther Metals PLC - mineral exploration company focused on Canada - Notes announcement of Panther Metals Ltd, in which it has 37% holding, detailing "significant" reverse circulation drilling sample assay results. Results from the Coglia nickel cobalt project in Western Australia include: 21 metres at 1.34% nickel from 72 metres and 10 metres at 1.3% nickel from 62 metres. 18 of the 26 holes assayed return results above 0.5% nickel and 500 parts per million of copper. Once drilling is complete at Coglia the drill rig will move to the Eight Foot Well gold prospect, the company adds.

----------

Cohort PLC - Reading, England-based technology company - Says its German subsidiary ELAC Sonar has been awarded a contract to supply hydroacoustic equipment by Fassmer Shipyard, on behalf of the Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support. Contract is worth EUR4 million and is expected to complete in the final quarter of 2023.

----------

Tern PLC - London-based investor focused on the internet of things - Notes that Wyld Networks AB has received a purchase order for its Wyld Connect internet of things module from an unnamed Brazilian company in the forestry sector. Tern holds 59% of Wyld Networks.

----------

Capital Metals PLC - London-based mineral sands explorer - Says IHC Mining is nearing the completion of the development study for the Eastern Minerals project in Sri Lanka. Capital Metals expects the final report by mid-April. Adds that drill samples from the project are continuing to be assayed by an independent laboratory but warns of backlogs. Company working with Sri Lankan government to secure industrial mining license but says timeline is beyond their control. Discussion regarding offtake and strategic party agreements continue.

----------

By Heather Rydings; heatherrydings@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 Mar 2024 11:22

ValiRx inks evaluation deal with Imperial College London for research

(Alliance News) - ValiRx PLC on Thursday said that it has signed an evaluation deal with Imperial College London to look at research on novel therapeutic candidates for cancer treatment.

Read more
19 Mar 2024 19:47

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Feb 2024 14:45

ValiRx says requisition notice from shareholder group is invalid

(Alliance News) - ValiRx PLC on Tuesday said a requisition notice, which it received earlier in February, has been confirmed as invalid following legal advice.

Read more
12 Feb 2024 12:59

ValiRx inks deal with Dundee Drug Discovery Unit

(Sharecast News) - ValiRx announced the signing of a significant agreement with the University of Dundee and its Drug Discovery Unit (DDU) on Monday.

Read more
12 Feb 2024 11:42

IN BRIEF: ValiRx signs research sharing deal with Dundee University

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics.

Read more
9 Feb 2024 20:24

TRADING UPDATES: ValiRx receives shareholder request for board change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Dec 2023 15:56

UK shareholder meetings calendar - next 7 days

Friday 29 December 
Apollon Formularies PLCAGM
Eco Atlantic Oil & Gas LtdAGM
Genedrive PLCAGM
Goldplat PLCAGM
Lansdowne Oil & Gas PLCGM re capital raise
Marula Mining PLCAGM
Microsaic Systems PLCGM re fundraise
Online Blockchain PLCAGM
Secure Property Development & Investment PLCAGM
SkinBioTherapeutics PLCAGM
Tetragon Financial Group LtdAGM
Woodbois LtdAGM
Zambeef Products PLCAGM
Monday 1 January 
no events scheduled 
Tuesday 2 January 
no events scheduled 
Wednesday 3 January 
Jubilee Metals Group PLCGM re equity raise
Thursday 4 January 
Rotala PLCGM re management buyout
Tintra PLCGM re cancellation, re-registering as private company
ValiRx PLCGM re operational review
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
19 Dec 2023 20:46

IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares.

Read more
13 Dec 2023 21:14

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
5 Dec 2023 15:08

ValiRx enters option deal with Ambrose Healthcare

(Sharecast News) - Cancer therapeutics-focussed life science company ValiRx announced on Tuesday that its subsidiary ValiSeek has entered into an exclusive option agreement with Ambrose Healthcare, a private UK-based pharmaceutical company.

Read more
5 Dec 2023 11:17

ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose

(Alliance News) - ValiRx PLC on Tuesday said that ValiSeek Ltd it has entered a deal to licence VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company.

Read more
5 Dec 2023 10:59

AIM WINNERS & LOSERS: tinyBuild warns on revenue; ValiRx rises

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Read more
10 Nov 2023 11:49

ValiRx signs deal to evaluate StingRay Bio drug candidates

(Alliance News) - ValiRx PLC on Friday said it has signed a deal with StingRay Bio Ltd to investigate a series of drug candidates.

Read more
10 Nov 2023 10:32

ValiRx enters partnership with StingRay Bio

(Sharecast News) - Life science company ValiRx announced a new partnership with StingRay Bio on Friday, aiming to explore a promising lead series of drug candidates designed for oncology applications.

Read more
6 Oct 2023 11:35

ValiRx sees no reason for shares jump; notes TheoremRx mulls merger

(Alliance News) - ValiRx PLC on Friday said it had no unpublished information that was sensitive to its share price, as it rose significantly.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.